Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report

INTRODUCTION: The clinical efficacy of osimertinib for patients with lung adenocarcinoma harboring epidermal growth factor receptor (EGFR) exon 20 insertion mutations is unclear. Few case reports exist on the successful treatment of such tumors with osimertinib. We report a case wherein osimertinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Inagaki, Yuji, Tamiya, Akihiro, Matsuda, Yoshinobu, Azuma, Kouji, Adachi, Yuichi, Enomoto, Takatoshi, Kouno, Shunichi, Taniguchi, Yoshihiko, Saijo, Nobuhiko, Okishio, Kyoichi, Atagi, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572000/
https://www.ncbi.nlm.nih.gov/pubmed/33080698
http://dx.doi.org/10.1097/MD.0000000000022628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572000/
https://www.ncbi.nlm.nih.gov/pubmed/33080698
http://dx.doi.org/10.1097/MD.0000000000022628

Ejemplares similares